Patents by Inventor Ningfeng Li

Ningfeng Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11690813
    Abstract: Members of the PrC-210 family of aminothiols, including PrC-211 and PrC-252, are shown to be highly effective in reducing ischemia-reperfusion injury in two preclinical models, including kidney transplant and myocardial infarct. Compositions and methods employing members of the PrC-210 family of aminothiols are disclosed for suppressing ischemia-reperfusion-induced cell and organ toxicities in a number of settings, significantly including organ transplant and myocardial infarct.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: July 4, 2023
    Assignee: OBVIA PHARMACEUTICALS LTD
    Inventors: William E. Fahl, Ningfeng Li
  • Patent number: 11209437
    Abstract: Provided are a fluorescent probe and a preparation process and the use thereof. The fluorescent probe is sensitive and specific to viscosity, and can be used for specific fluorescent labeling of proteins, and can also be used for quantification, detection or kinetic studies of proteins, and the imaging of cells, tissues and living bodies.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: December 28, 2021
    Assignee: FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY
    Inventors: Linyong Zhu, Yi Yang, Dasheng Zhang, Zengmin Du, Bingkun Bao, Qiuning Lin, Xianjun Chen, Lipeng Yang, Chunyan Bao, Yihui Ge, Renmei Liu, Zhengda Chen, Sitong Zhang, Ningfeng Li, Xin Hua
  • Publication number: 20210299066
    Abstract: Members of the PrC-210 family of aminothiols, including PrC-211 and PrC-252, are shown to be highly effective in reducing ischemia-reperfusion injury in two preclinical models, including kidney transplant and myocardial infarct. Compositions and methods employing members of the PrC-210 family of aminothiols are disclosed for suppressing ischemia-reperfusion-induced cell and organ toxicities in a number of settings, significantly including organ transplant and myocardial infarct.
    Type: Application
    Filed: January 4, 2019
    Publication date: September 30, 2021
    Inventors: William E. Fahl, Ningfeng Li
  • Publication number: 20200248069
    Abstract: Provided are a fluorescent probe, a preparation method therefor and a use thereof. The fluorescent probe responds to viscosity sensitively and specifically, can be used for the specific fluorescence labeling of proteins and can also be used in the quantification, detection or kinetic study of proteins and the imaging of cells, tissues and living bodies.
    Type: Application
    Filed: September 29, 2018
    Publication date: August 6, 2020
    Applicant: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Linyong Zhu, Yi Yang, Bingkun Bao, Chenxia Zhang, Dasheng Zhang, Chunyan Bao, Qiuning Lin, Ningfeng Li, Xin Hua, Yongliang Zhao, Renmei Liu, Zhengda Chen, Yuying Sun
  • Publication number: 20190187144
    Abstract: Provided are a fluorescent probe and a preparation process and the use thereof. The fluorescent probe is sensitive and specific to viscosity, and can be used for specific fluorescent labeling of proteins, and can also be used for quantification, detection or kinetic studies of proteins, and the imaging of cells, tissues and living bodies.
    Type: Application
    Filed: July 18, 2017
    Publication date: June 20, 2019
    Applicant: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Linyong Zhu, Yi Yang, Dasheng Zhang, Zengmin Du, Bingkun Bao, Qiuning Lin, Xianjun Chen, Lipeng Yang, Chunyan Bao, Yihui Ge, Renmei Liu, Zhengda Chen, Sitong Zhang, Ningfeng Li, Xin Hua